Research
Neural
Use of incretin-based therapies (IBT) after bariatric surgery is associated with a 55% lower risk of new-onset alcohol use disorder (AUD) compared to non-IBT antiobesity medications (AOMs).
Practitioners may consider prescribing IBT for patients post-bariatric surgery to reduce the risk of AUD.
StrongSupportsmedium confidence
In this cohort study of patients who underwent bariatric surgery, IBT was associated with a 55% lower risk of new-onset AUD compared with non-IBT AOMs.
Why this rating
Based on a large retrospective cohort study design.
Source
Incretin-Based Therapies and Post–Bariatric Surgery Alcohol Use Disorder
Butros Fakhoury et al. · JAMA Network Open · 2025
cohort · n=15382Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →